Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 23;73(20):474-476.
doi: 10.15585/mmwr.mm7320a4.

Notes from the Field: Clade II Mpox Surveillance Update - United States, October 2023-April 2024

Alexandra Tuttle, Christine M Hughes, Mitchell Dvorak, Leah Aeschleman, Whitni Davidson, Kimberly Wilkins, Crystal Gigante, Panayampalli S Satheshkumar, Agam K Rao, Faisal S Minhaj, Bryan E Christensen, Jennifer H McQuiston, Christina L Hutson, Andrea M McCollum

Notes from the Field: Clade II Mpox Surveillance Update - United States, October 2023-April 2024

Alexandra Tuttle et al. MMWR Morb Mortal Wkly Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Clade II mpox cases (probable* and confirmed†), by epidemiologic week — United States, May 2022–April 2024§ Abbreviations: IgM = immunoglobulin M; MPXV = monkeypox virus; PCR = polymerase chain reaction. *Probable cases are defined as infections in persons with no suspicion of other recent Orthopoxvirus exposure (e.g., Vaccinia virus in ACAM2000 vaccination) and demonstration of the presence of at least one of the following criteria: 1) Orthopoxvirus DNA by PCR testing of a clinical specimen, 2) Orthopoxvirus using immunohistochemical or electron microscopy testing methods, or 3) demonstration of detectable levels of antiorthopoxvirus IgM antibody during the 4–56 days after rash onset. † Confirmed cases are defined as demonstrated presence of MPXV DNA by PCR testing or next-generation sequencing of a clinical specimen or isolation or MPXV in culture from a clinical specimen. § Data on confirmed and probable mpox cases collected by jurisdictional public health departments and electronically reported through the National Notifiable Disease Surveillance System or via a standardized case report form.
See this image and copyright information in PMC

References

    1. McQuiston JH, Luce R, Kazadi DM, et al. U.S. preparedness and response to increasing clade I mpox cases in the Democratic Republic of the Congo—United States, 2024. MMWR Morb Wkly Rep 2024;73:435–40. 10.15585/mmwr.mm7319a3 - DOI - PMC - PubMed
    1. CDC. Mpox clinical considerations for treatment and prophylaxis of mpox in people who are immunocompromised. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. Accessed May 20, 2024. https://www.cdc.gov/poxvirus/mpox/clinicians/people-with-HIV.html
    1. CDC. Mpox: JYNNEOS vaccine coverage by jurisdiction. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. Accessed April 24, 2024. https://www.cdc.gov/poxvirus/mpox/cases-data/mpx-jynneos-vaccine-coverag...